Elliptinium acetate
Term · Oncology and biomedicine · MLC-T-ONC-013309
Acetate salt of elliptinium, a derivative of the alkaloid ellipticine isolated from species of the plant family Apocynaceae, including Bleekeria vitensis, a plant with anti-cancer properties. As a topoisomerase II inhibitor and intercalating agent, elliptinium stabilizes the cleavable complex of topoisomerase II and induces DNA breakages, thereby inhibiting DNA replication and RNA and protein synthesis.
| Identifier | MLC-T-ONC-013309 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | NMHE |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013309",
"term": "Elliptinium acetate",
"field": "Oncology and biomedicine",
"definition": "Acetate salt of elliptinium, a derivative of the alkaloid ellipticine isolated from species of the plant family Apocynaceae, including Bleekeria vitensis, a plant with anti-cancer properties. As a topoisomerase II inhibitor and intercalating agent, elliptinium stabilizes the cleavable complex of topoisomerase II and induces DNA breakages, thereby inhibiting DNA replication and RNA and protein synthesis.",
"abbreviation": "NMHE",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/elliptinium-acetate/"
}
Record 6,549 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.